Predictors of Alcohol Relapse Following Liver Transplantation for Alcohol-Induced Liver Failure. Consideration of "A-D" Selection Criteria.

Ann Transplant

Section of Hepatology, Department of Internal Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.

Published: February 2018

Demonstrated abstinence from alcohol for over six months and successful completion of a formal alcohol addictions program are two commonly employed criteria for determining whether an alcoholic patient with liver failure should proceed to liver transplantation. In this systematic review of the medical literature, we review the justification for these criteria and consider other variables that have also been reported to be of predictive value. While abstinence from alcohol for over six months is supported by the medical literature, data are more limited regarding the value of formal alcohol addictions program as selection criteria for proceeding towards liver transplantation. Positive family histories of alcoholism, co-inhabitants drinking alcohol in the presence of the patient and concurrent drug dependencies are more robust predictor variables of post-transplant recidivism. Based on the findings of this review, we propose a simple A-D transplantation selection criteria wherein "A" refers to demonstrated abstention from alcohol for over six months, "B" biology (a negative family history for alcoholism), "C", co-inhabitants not consuming alcohol in the presence of the patient; and "D", no concurrent drug dependency.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6248322PMC
http://dx.doi.org/10.12659/AOT.905646DOI Listing

Publication Analysis

Top Keywords

liver transplantation
12
selection criteria
12
alcohol months
12
liver failure
8
abstinence alcohol
8
formal alcohol
8
alcohol addictions
8
addictions program
8
medical literature
8
alcohol presence
8

Similar Publications

Introduction: In solid-organ transplant (SOT) recipients, while survival rates have improved with immunosuppressive therapies, the risk of opportunistic infections has also increased. This study aimed to evaluate the frequency of pneumonia, identify microbiological factors, investigate diagnostic methods, and analyse prognosis.

Materials And Methods: A retrospective study was conducted to identify adult SOT recipients referred to the pulmonary diseases department with a preliminary pneumonia diagnosis between 2011 and 2019.

View Article and Find Full Text PDF

Ampullary composite gangliocytoma/neuroma and neuroendocrine tumor (CoGNET), previously called ampullary gangliocytic paragangliomas (GP) are a rare entity, with only few reported cases in the literature. This is a multicentric retrospective cohort of patients treated with endoscopy or surgery for ampullary CoGNET. A literature review of ampullary CoGNET was also performed.

View Article and Find Full Text PDF

Introduction: Primary sclerosing cholangitis (PSC) is a biliary disorder associated with a high risk of end-stage liver disease and cholangiocarcinoma (CCA). Currently prediction of the unfavorable outcomes is hindered by the lack of valuable prognostic biomarkers.

Objectives: The aim of the study was to assess the prevalence of the autoantibodies in PSC and define their potential use as the predictors of progressive disease and CCA in a large, prospective cohort of PSC patients.

View Article and Find Full Text PDF

Acute liver failure (ALF) is a rare, life-threatening condition that may be secondary to drug-induced liver injury (DILI) and certain viral infections. We present the case of a 73-year-old male with a history of fibrotic hypersensitivity pneumonitis with a progressive phenotype, type 2 diabetes mellitus, hypertension, and hyperlipidemia, who was admitted with ALF potentially secondary to DILI. Prior to admission, he was receiving therapy that may be related to idiosyncratic DILI (I-DILI) and ALF, namely nintedanib, which appears to have a most probable relation to I-DILI in this case, considering it was the most recently started drug.

View Article and Find Full Text PDF

Outpatient management after hospitalisation for acute decompensation of cirrhosis: A practical guide.

World J Hepatol

December 2024

Fourth Department of Internal Medicine, Aristotle University of Thessaloniki, Hippokration General Hospital, Thessaloniki 54642, Greece.

Acute decompensation in cirrhotic patients signifies the onset of clinically evident events due to portal hypertension. The transition from compensated to decompensated cirrhosis involves hemodynamic changes leading to multiorgan dysfunction, managed predominantly in outpatient settings with regular monitoring. The mortality risk is elevated in decompensated patients.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!